Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | DEFA14A: Others
Aquestive Therapeutics | DEF 14A: Definitive information statements
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Aquestive Therapeutics Reports Third Quarter 2023 Financial Results
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | 8-K: Current report
Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aquestive Therapeutics | 8-K: Current report
No Data